Sun's generic of anticoagulant Plavix receives FDA approval

07/31/2011 | Business Standard (India)

The FDA is allowing Sun Pharmaceutical Industries to launch a 75-milligram dose of clopidogrel USP, a generic version of Sanofi and Bristol-Myers Squibb's anticoagulant Plavix. The tablet is given to patients with "acute coronary syndrome, recent myocardial infarction ... recent stroke or established peripheral arterial disease," Sun said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA